Latest stories on INMB
Inmune Bio, Inc. (INMB) files 8-K
SEC 8-K50 · neutralgeneral
INmune Bio Receives R&D Rebates of Approximately $4.6 Million
Business Insider59 · neutralgeneral
INmune Bio Inc. to Report Second Quarter 2026 Financial Results and Provide Corporate Update on Thursday, August 6th
Business Insider50 · neutralgeneral
INmune Bio Receives R&D Rebates of Approximately $4.6 Million
StockTitan55 · neutralgeneral
INmune Bio Establishes Scientific Advisory Board to Support Late-Stage Development and Expansion of CORDStrom™ Platform
StockTitan56 · neutralproduct/pr
INmune Bio Completes Commercial Manufacturing Milestone Supporting Planned Global Registration Filings for CORDStrom™ Platform
StockTitan63 · neutralproduct/pr
INmune Bio to Present Positive Phase 2 Imaging Data for XPro in Early Alzheimer’s Disease at AAIC | INMB Stock News
StockTitan73 · bullishproduct/pr
INmune Bio Executes Warrant Inducement and Extension Agreement
TipRanks50 · neutralgeneral
Inmune Bio, Inc. (INMB) files 8-K
SEC 8-K50 · neutralgeneral
INmune Bio Inc. Achieves MHRA Approval of PIP for CORDStrom™ | INMB Stock News
StockTitan67 · bullishproduct/pr
INmune Bio Advances Ebstrocel Toward UK Conditional Approval
TipRanks67 · bullishproduct/pr
Inmune Bio, Inc. (INMB) files 8-K
SEC 8-K50 · neutralgeneral
Inmune Bio Shareholders Reaffirm Board, Auditor and Incentive Plan
TipRanks50 · neutralgeneral
Inmune Bio, Inc. (INMB) files 8-K
SEC 8-K50 · neutralgeneral
INmune Bio reports positive Phase 2 MRI results
TipRanks67 · bullishproduct/pr
INmune Bio (INMB) Q1 2026 Earnings Transcript
Yahoo Top50 · neutralearnings